    [Federal Register Volume 85, Number 168 (Friday, August 28, 2020)]
    [Notices]
    [Pages 53397-53398]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 2020-19012]

    =======================================================================
    -----------------------------------------------------------------------

    INTERNATIONAL TRADE COMMISSION

    [Investigation No. 337-TA-1182]

    Certain Argon Plasma Coagulation System Probes, Their Components,
    and Other Argon Plasma Coagulation System Components for use Therewith;
    Commission Determination Not to Review an Initial Determination
    Terminating the Investigation in Its Entirety; Termination of
    Investigation

    AGENCY: International Trade Commission.

    ACTION: Notice.

    -----------------------------------------------------------------------

    SUMMARY: Notice is hereby given that the U.S. International Trade
    Commission (``Commission'') has determined not to review an initial
    determination (``ID'') (Order No. 21) of the presiding administrative
    law judge (``ALJ''), terminating the investigation in its entirety
    based on a settlement agreement.

    FOR FURTHER INFORMATION CONTACT: Ronald Traud, Esq., Office of the
    General Counsel, U.S. International Trade Commission, 500 E Street SW,
    Washington, DC 20436, telephone (202) 205-3427. Copies of non-
    confidential documents filed in connection with this investigation may
    be viewed on the Commission's electronic docket (EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
    EDIS3Help@usitc.gov. General information concerning the Commission may
    also be obtained by accessing its internet server at https://www.usitc.gov. Hearing-impaired persons are advised that information on
    this matter can be obtained by contacting the Commission's TDD terminal
    on (202) 205-1810.

    SUPPLEMENTARY INFORMATION: The Commission instituted this investigation
    on November 8, 2019, based on a complaint filed by Erbe Elektromedizin
    GmbH of the Republic of Germany and Erbe USA, Inc. of Marietta, Georgia
    (collectively, ``Erbe''). 84 FR 60451 (Nov. 8, 2019). The complaint
    alleges violations of section 337 of the Tariff Act of 1930, as
    amended, 19 U.S.C. 1337 based upon the importation into the

    [[Page 53398]]

    United States, the sale for importation, or the sale within the United
    States after importation of certain argon plasma coagulation system
    probes, their components, and other argon plasma coagulation system
    components for use therewith by reason of infringement of certain
    claims of U.S. Patent Nos. D577,671; 7,311,707; 7,717,911; 9,510,889;
    and 9,603,653. Id. The complaint further alleges that a domestic
    industry exists. Id. After an amendment to the notice of investigation
    and complaint, 85 FR 12016 (Feb. 28, 2020), the respondents to the
    investigation are: (1) Olympus Corporation of Tokyo, Japan; (2) Olympus
    Corporation of the Americas of Center Valley, Pennsylvania; (3) Olympus
    America of Center Valley, Pennsylvania; (4) Olympus Surgical
    Technologies Europe of Hamburg, Republic of Germany; (5) Olympus Winter
    & lbe GmbH of Hamburg Republic of Germany; and (6) Gyrus Medical Ltd
    (collectively, ``Olympus''). The Office of Unfair Import Investigations
    (``OUII'') is participating in the investigation. 84 FR at 60452.
        On July 27, 2020, Erbe and Olympus filed a joint motion to
    terminate this investigation based on a settlement agreement. On August
    6, 2020, OUII filed a response supporting the motion.
        On August 10, 2020, the presiding ALJ issued Order No. 21, the
    subject ID, which grants the motion. The ID finds that the joint motion
    complies with Commission Rules 210.21(b)(1) and 201.6(a). The ID
    additionally finds that terminating the investigation would not
    adversely affect the public interest. No petitions for review were
    filed.
        The Commission has determined not to review the subject ID. The
    investigation is hereby terminated in its entirety.
        The Commission vote for this determination took place on August 25,
    2020.
        The authority for the Commission's determination is contained in
    section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and
    in Part 210 of the Commission's Rules of Practice and Procedure (19 CFR
    part 210).

        By order of the Commission.

        Issued: August 25, 2020.
    Lisa Barton,
    Secretary to the Commission.
    [FR Doc. 2020-19012 Filed 8-27-20; 8:45 am]
    BILLING CODE 7020-02-P